Ligand profile
ZINC1903864090
Virtual-screening candidate from ZINC.
Bound to: VK055_1865 — penicillin-binding protein 2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1903864090- UniProt (similar protein)
P0AD65- Tanimoto
- 0.649
- Target protein
- VK055_1865
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 88.5
- −1 ≤ LogP ≤ 5 2.41
- MW ≤ 500 Da 439.6
- LogP ≤ 5 2.41
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 88.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@H](N=CN3CCCCCC3)[C@H]2SC1(C)CCC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@H](N=CN3CCCCCC3)[C@H]2SC1(C)C
InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15-,17+/m0/s1InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15-,17+/m0/s1
NPGNOVNWUSPMDP-YQQAZPJKSA-NNPGNOVNWUSPMDP-YQQAZPJKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL530
- Homolog
- P0AD65
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1903864090 →
- ZINC ZINC20 ZINC1903864090 →
- UniProt UniProt P0AD65 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1903864090”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1865.
PDB 25
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).